Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 2,232.0 | 2,728.0 | 2,209.0 | 3,081.0 | 960.1 | 5,474.7 | 7,138.1 | 6,439.7 |
| Revenue growth | -18.2% | 23.5% | -28.3% | 220.9% | -82.5% | -23.3% | 10.8% | 21.4% |
| Cost of goods sold | 779.0 | 671.0 | 609.0 | 721.0 | 2,537.2 | 2,469.5 | 4,276.8 | 3,814.4 |
| Gross profit | 1,453.0 | 2,057.0 | 1,600.0 | 2,360.0 | -1,577.1 | 3,005.2 | 2,861.3 | 2,625.3 |
| Gross margin | 65.1% | 75.4% | 72.4% | 76.6% | -164.3% | 54.9% | 40.1% | 40.8% |
| Sales and marketing | 180.0 | 160.0 | 143.0 | 205.0 | | | | |
| General and administrative | 274.0 | 216.0 | 191.0 | 187.0 | 162.5 | 159.3 | 143.2 | 138.5 |
| EBITA | 799.0 | 1,526.0 | 1,088.0 | 1,824.0 | 1,870.2 | 1,632.1 | 1,575.0 | 1,573.2 |
| EBITA margin | 35.8% | 55.9% | 49.3% | 59.2% | 194.8% | 29.8% | 22.1% | 24.4% |
| Amortization of intangibles | 26.0 | 29.0 | 34.0 | 48.0 | 112.9 | 114.2 | 309.5 | 311.4 |
| EBIT | 773.0 | 1,497.0 | 1,054.0 | 1,776.0 | 1,757.3 | 1,517.9 | 1,265.5 | 1,261.8 |
| EBIT margin | 34.6% | 54.9% | 47.7% | 57.6% | 183.0% | 27.7% | 17.7% | 19.6% |
| Pre-tax income | 300.0 | 1,044.0 | 301.0 | 662.0 | 1,215.0 | 1,062.5 | 837.0 | 931.6 |
| Income taxes | 76.0 | 247.0 | 93.0 | 156.0 | 269.5 | 293.3 | 319.4 | 326.2 |
| Tax rate | 25.3% | 23.7% | 30.9% | 23.6% | 22.2% | 27.6% | 38.2% | 35.0% |
| Earnings from continuing ops | 224.0 | 797.0 | 208.0 | 506.0 | 945.5 | 769.2 | 515.8 | 596.5 |
| Earnings from discontinued ops | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | |
| Net income | 223.0 | 801.0 | 214.0 | 278.0 | 963.1 | 788.7 | 515.8 | 596.5 |
| Net margin | 10.0% | 29.4% | 9.7% | 9.0% | 100.3% | 14.4% | 7.2% | 9.3% |
| |
| Diluted EPS | $4.48 | $15.94 | $4.34 | $9.94 | $17.16 | $13.76 | $8.76 | $9.57 |
| Shares outstanding (diluted) | 50.0 | 50.0 | 47.9 | 50.9 | 55.1 | 55.9 | 58.9 | 62.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|